Registered entities
ADC THERAPEUTICS AMERICA, INC.
Reg. No. 473367212United States
ADC THERAPEUTICS (UK) LIMITED
Reg. No. 9353055Germany
Innovation
15 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 259 times.
| Year | Filings |
|---|---|
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 1 |
| 2017 | 9 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2022 | 1 |
Social engagement
Social engagement: 23.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Auven Therapeutics, MedImmune, AstraZeneca; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 57% |
| Private equity | 2 | 14% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 3 | 21% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
2 Feb 2026 · Medical Science Liaison (Northeast) · New Boston
Based on job postings tracked across public sources.
Recent activity
30 Jun 2026
Milestone
regulatory
28 May 2026
Recognition
26 May 2026
Recognition